News

Hyderabad: City startup achieves global first in regenerative medicine for liver failure
ASPIRE-BioNEST at UoH and Tulsi Therapeutics announce world’s first successful pre-clinical trial of Stem Cell–Exosome ...
Hyderabad startup reverses chronic liver failure in animal trials
HYDERABAD: A Hyderabad-based startup, Tulsi Therapeutics, has demonstrated the complete reversal of chronic liver failure in ...
City startup incubated at UoH develops stem cell treatment for chronic liver failure
Hyderabad: A startup incubated at the University of Hyderabad (UoH) successfully tested a new treatment for chronic liver ...
Hyd-based Tulsi Therapeutics achieves global first in regenerative medicine for liver failure
In a landmark moment for India’s biotechnology sector, Hyderabad-based biotech startup Tulsi Therapeutics, which focused on regenerative medicine using stem cells and exosomes, and ASPIRE-BioNEST, ...
Tulsi Therapeutics completes pre-clinical trials of stem cell–exosome therapy for liver failure
Tulsi Therapeutics achieves groundbreaking success in animal trial for liver disease treatment, paving way for human trials.
University of Hyderabad incubated startup announces successful animal trials of stem cell therapy for liver failure
Tulsi Therapeutics achieves groundbreaking success with novel stem cell–exosome therapy for chronic liver failure at ...
Hyderabad biotech startup reverses chronic liver failure in preclinical trials with novel stem cell therapy
Tulsi Therapeutics, a biotech startup from Hyderabad, has reversed chronic liver failure in animal trials using Tulsi-28X, a ...